Gastric
- What is the optimal management strategy for patients with advanced gastric cancer and positive peritoneal cytology without clinically evident peritoneal carcinomatosis?
- Subgroups - cytology positive and converted to negative
- What is the comparative efficacy of intraperitoneal chemotherapy administration methods for GCPM?
Abstraction Summaries
Copy Link
Gastric Prospero Protocols
Copy Link
- Role of Intraperitoneal Chemotherapy in Patients with Advanced Gastric Cancer without Peritoneal Metastases: A Rapid Review.Samuel Butensky, Varun Bansal, Kiran Turaga, Craig Gunderson, Kurt Schultz. PROSPERO 2023 CRD42023466028
- Treatment of gastric cancer with peritoneal metastases with cytoreductive surgery and intraperitoneal chemotherapy: A Rapid Review.Samuel Butensky, Kiran Turaga, Kurt Schultz, Varun Bansal, Craig Gunderson. PROSPERO 2023 CRD42023466032
- Management of cytology positive gastric cancer: A rapid review.Samuel Butensky, Kiran Turaga, Varun Bansal, Kurt Schultz, Craig Gunderson. PROSPERO 2023 CRD42023466035
- Systemic Therapies in Patients Undergoing Cytoreductive Surgery with Intraperitoneal Chemotherapy for Advanced Gastric Cancer: A Rapid Review.Samuel Butensky, Kiran Turaga, Varun Bansal, Kurt Schultz, Craig Gunderson. PROSPERO 2023 CRD42023466036
Need Accessibility Assistance?
If you are having trouble viewing or accessing this content, please contact David by email.